Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06768918

Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries

Led by Zealand University Hospital · Updated on 2026-03-12

300

Participants Needed

5

Research Sites

117 weeks

Total Duration

On this page

Sponsors

Z

Zealand University Hospital

Lead Sponsor

K

Klaipėda University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Background With increasing cancer incidence and advanced cancer treatment, the growing population of cancer survivors increases the demand on health resources worldwide. Over the last 20 years, physical rehabilitation has reached recognition as an essential component of cancer care due its effect on physical function, side effects of treatment, and quality of life. However, highly specialized health care can result in longer distances to rehabilitation facilities. Also, a heavy appointment schedule for patients in treatment tends to complicate participation in rehabilitation. Telehealth has shown promise in increasing accessibility to services, also rehabilitation. However, barriers to participating in digitally delivered rehabilitation might exist, including lower e-health literacy and internet access in rural areas. The aim of this study is therefore, to examine the feasibility of implementing digitally supported rehabilitaiton in cancer care during and after treatment. Methodology In a multinational implementation study, the feasibility of implementation of digital rehabilitation will be tested in five South Baltic Countries (DK, SWE, GER, PL, LTU). Each site will host one feasibility trial for patients during cancer treatment and one for patients after, with n=30 patients in each fesibility trial (total n=300). The intervention will be needs-based, follow international guidelines, last from 8-16 weeks, and be delivered by trained Health Care Professionals (HCP's), either fully or partially digital. Mixed methods will be used to assess outcomes of reach, effectiveness, adoption, implementation and maintenance (RE-AIM). Through the coordinated feasibility trials across five South Baltic countries, the investigators expect to learn about important factors in implementation of digitally delivered rehabilitation in different settings, cultures, and health systems. Finally, the investigators will bring recommendations for improving reach, implementation, and sustainability of digitally delivered rehabilitation across different settings.

CONDITIONS

Official Title

Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with cancer (IDC: C00* - C97*)
  • For early rehab study: receiving any systemic chemo/immunotherapy preferably lasting 8 weeks or more
  • For early rehab study: recruitment preferably within 4 weeks of treatment start
  • For rehab@home study: completed chemo/immunotherapy no more than 6 months ago or receiving long-term maintenance therapy
  • Able to participate in physical or psychological rehabilitation normally referred to physiotherapy or exercise specialists in cancer care
Not Eligible

You will not qualify if you...

  • Unable to give consent or participate in digital rehabilitation due to cognitive impairment as judged by project staff

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Zealand Unievrsity Hospital

Næstved, Denmark, 4700

Actively Recruiting

2

University Medical Center Rostock

Rostock, Germany, 18057

Actively Recruiting

3

Klaipeda University

Klaipėda, Lithuania, LT-92294

Actively Recruiting

4

Medical University of Gdansk

Gdansk, Poland, 80-210

Actively Recruiting

5

Ängelholm Hospital

Ängelholm, Sweden, 26281

Actively Recruiting

Loading map...

Research Team

G

Gunn Ammitzbøll, PhD

CONTACT

S

susanne O Dalton, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here